Aimmune Therapeutics, Inc. 4
4 · Aimmune Therapeutics, Inc. · Filed May 30, 2017
Insider Transaction Report
Form 4
Seltzer Stacey Denenberg
Director
Transactions
- Award
Stock Option (right to buy)
2017-05-25+17,500→ 17,500 totalExercise: $18.26Exp: 2027-05-25→ Common Stock (17,500 underlying)
Footnotes (1)
- [F1]The shares subject to the option will vest and become exercisable as to 100% of the total number of shares subject to the option on the earlier of (i) the first anniversary of the grant date or (ii) the date of the 2018 Annual Meeting of the Issuer's stockholders, assuming continuous service as a director until such vesting date.